Clinical trials
Completed Memory Disorders trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2017 | 4 |
| 2018 | 2 |
| 2022 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AZTherapies, Inc. | 1 |
| AbbVie | 1 |
| Eisai Inc. | 1 |
| Eli Lilly and Company | 1 |
| Global Alzheimer's Platform Foundation | 1 |
| Ionis Pharmaceuticals, Inc. | 1 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1 |
| Queen's University | 1 |
| University Health Network, Toronto | 1 |
| University of Manitoba | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Memory Disorders | 13 |
| Alzheimer Disease | 6 |
| Cognitive Dysfunction | 4 |
| Dementia | 4 |
| Pick Disease of the Brain | 2 |
| Tauopathies | 2 |
| Cognition Disorders | 1 |
| Learning Disabilities | 1 |
| Major Depressive Disorder | 1 |
| Nervous System Diseases | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.